BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Acasti Pharma 

225 Promenade du Centropolis
Suite 200
Laval  Quebec  H7T 3B3  Canada
Phone: 450-687-2262 Fax: 450-687-2272


SEARCH JOBS




Industry
Pharmaceutical

Segment
Pharmaceuticals





 Company News
Acasti Pharma Announces Grant Of Stock Options 10/20/2014 6:15:57 AM
Acasti Pharma Announces Second Quarter Results 10/14/2014 1:40:28 PM
Acasti Pharma Announces Positive Top-Line Pharmacokinetic Results 9/30/2014 7:04:00 AM
Acasti Pharmai Reports Successful Capre® Phase 2 TRIFECTA Results Proving Statistically Significant Improvements In Triglycerides & Non-HDL-C 9/29/2014 9:02:43 AM
Acasti Pharma Announces Oral Presentation On COLT Study Results At 19th World Congress On Heart Disease In Boston 7/24/2014 9:55:44 AM
Acasti Pharma Announces First Quarter Results 7/16/2014 5:50:38 AM
Acasti Pharma Completes Phase 2 Double Blind (TRIFECTA) And Pharmacokinetic Trials 7/9/2014 10:37:09 AM
Neptune Technologies & Bioressources Inc., Acasti Pharma And Neurobiopharm's Ex-CEO Sues, Seeks Approximately $8.5 Million In Damages 5/30/2014 6:58:02 AM
Acasti Pharma Announces Pricing Of $20 Million Offering Of Units 11/27/2013 7:59:24 AM
Acasti Pharma Announces Second Quarter Results 10/15/2013 9:39:24 AM
12345